The largest database of trusted experimental protocols

9 protocols using rhosin

1

Inhibition of Protein Tyrosine Phosphatases

Check if the same lab product or an alternative is used in the 5 most similar protocols
3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide (PTP Inhibitor XXII), Rhosin, and NSC23766, PP2, and Ki8751 were all purchased form Merck Millipore (Darmstadt, Germany). TCS401 was purchased from Tocris Bioscience (Bristol, UK).
+ Open protocol
+ Expand
2

Cell Migration and Invasion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell migration and invasion assay was performed as previously described [35 (link)]. The cells were seeded into the upper chambers in FBS-free RPMI1640 medium after adding rhosin (Merck Millipore) or verteporfin (Cayman Chemical, Ann Arbor, MI, USA). The lower chambers were loaded with FBS-free RPMI1640 medium including 50 ng/mL SDF-1 (PeproTech, London, UK). The cell adhesion assay was performed as previously described [35 (link)].
+ Open protocol
+ Expand
3

Aβ42 peptide treatment of bEnd.3 cells and pericytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aβ42 peptide was purchased from American Peptide Company (Sunnyvale, CA, USA) and was prepared as previously described (Byun et al., 2015). It was dissolved in hexafluoroisopropanol for 72 h at room temperature (RT) and lyophilized. The peptide was then dissolved again in dimethylsulfoxide. Anti‐ZO‐1, anti‐Claudin 5 (Thermo Fisher Scientific, Waltham, MA, USA), anti‐GAPDH (Abcam, Cambridge, MA, USA), anti‐GFP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti‐CD31 (R&D Systems, Minneapolis, MN, USA), antiphospho CREB (Cell signaling Technology, Danvers, MA, USA), anti‐CREB (Cell signaling Technology), and anti‐Annexin A1 (Invitrogen, Carsbad, CA, USA) were used for Western blot analysis, and Anti‐ZO‐1 (Thermo Fisher Scientific) was used for immunofluorescence images. Y27632, MK801, and l‐glutamate were purchased from Sigma‐Aldrich Co. (St. Louis, MO, USA), Rhosin was purchased from Merck Millipore (Billerica, MA, USA), and human Annexin A1 (ANXA1) recombinant protein was purchased from MyBioSource (San Diego, CA, USA). For experiments, bEnd.3 cells and/or pericytes were treated with Aβ42 (2 μm and/or 5 μm; from 0 to 24 h, differently for each experiment), ANXA1 (1 μg mL−1 and/or 2 μg mL−1; for 24.5 h), Y27632 (30 μm; for 24 h), Rhosin (10 μm; for 24 h), l‐glutamate (30 μm; for 30 min or 24 h), and MK801 (10 μm; for 30 min or 24 h).
+ Open protocol
+ Expand
4

Plaque Assay for Oncolytic Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated at 2 × 105/well in 6-well plates. After 36 h, cells were infected with OVV-LG at an MOI of 0.001. After a 1-h incubation, E-MEM containing 0.8% methyl cellulose supplemented with 5% FBS and reagents was added to each well, and plaque sizes were calculated with a BZ-X700 microscope. Reagents used for plaque assays were as follows: nocodazole (Wako, Osaka, Japan), colchicine (Wako), cytochalasin D (Wako), Rhosin (Merck, Boston, MA, USA), ML-141 (Sigma, St. Louis, MO, USA), and NSC23766 (Abcam, Cambridge, UK).
+ Open protocol
+ Expand
5

Evaluating RhoA Inhibitors on Cell Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (1×104 per well) were seeded into 24-well plates in RPMI-1640 medium supplemented with 10% FBS (10% FBS/RPMI-1640); plates were incubated at 37°C in a 5% CO2 incubator. Cell growth was assessed using MTT reagent (Cell Count Reagent SF, #07553-44, Nacalai Tesque) starting 24 h after seeding, and analysis was repeated every 24 h thereafter by measuring the absorbance at 450 nm using an iMark microplate reader (#1681135JA, Bio-Rad). To assess the effect of RhoA inhibitors, culture medium was replaced with fresh medium containing 15 µM Y16 (#Y-12649, MedChemExpress, NJ, USA) or 20 µM Rhosin (#555460, Merck, NJ, USA) at 24 h after seeding the cells.
+ Open protocol
+ Expand
6

Evaluating Rho GTPase Inhibitors on Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rho family GTPase inhibitors ML141 (Sigma-Aldrich), NSC23766 (Santa Cruz Biotech), ZCL278 (Tocris Bioscience), and Rhosin (Merck Milipore) were used at 15 μM, 50 μM, and 30 μM in i293-GFP and i293-GFP-ST and at 30 μM, 75 μM, and 60 μM in MCC13 cells. The integrin inhibitor RGDS (Tocris Bioscience) was used at a range of concentrations (see Results) on both 293-derived cells and MCC13 cells. Cell toxicity was measured using an MTS-based CellTiter 96 AqueousOne solution proliferation assay (Promega), as previously described (81 (link)).
+ Open protocol
+ Expand
7

Inhibition of GEF and ROCK in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GEF inhibitor Rhosin (Millipore-Sigma 555460) was added to cells at 25 uM final concentration upon transfection, 24 hours before imaging. ROCK inhibitor Y-27632 (Millipore-Sigma Y0503) was similarly added to cells at 10 uM final concentration.
+ Open protocol
+ Expand
8

RHOA Binding Kinetics via SPR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface Plasmon Resonance (SPR) was used to study the binding of RHOA protein to synthesized small molecules. Reichert SR7500DC system was used, and RHOA (SRP5127, Sigma Aldrich) protein was immobilized on CMDH gold chip (Reichert) at <7 μg and a flow rate of 10 μl/min. Rhosin (Millipore) and compounds JK-121~125 were dissolved in DMSO. Immobilized RHOA resulted in 2550 resonance units (RU). CLAMP© program [46 (link)] was used to analyzed the kinetics of protein-small molecule binding.
+ Open protocol
+ Expand
9

Ratiometric FRET Imaging of RhoA Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FRET channel was divided by the CFP channel, then multiplied by a scaling factor to bring the image back to the 16-bit dynamic range for visualization purposes. The ratiometric FRET image, rFRET, was calculated using the following equation:
[rFRET]=[FRET]corr[CFP]corr×Scaling factor
where [FRET]corr and [CFP]corr are the corrected images of FRET and CFP channels respectively.
The final images were then corrected for photobleaching using the biexponential intensity decay model described in Spiering et al[34 (link),36 (link)].
To validate the cell line with the FRET biosensor, we modulated RhoA activity by treating cells with CN03, a constitutive RhoA activator (CN03, Cytoskeleton, Inc.)[51 (link)], and Rhosin (Fig. S4), a RhoA inhibitor[52 (link)]. CN03 activates RhoA GTPase by deamidating glutamine-63, which is located at the Switch II region[52 (link)]. This allows constitutive activation of RhoA without altering the availability of Switch I region for binding with Rho-Binding Domain (RBD) within the biosensor.
On the other hand, Rhosin (555460-M, Millipore) is an RhoA inhibitor which targets the RhoGEF binding domain of RhoA[52 (link)]. We found that Rhosin treatment reduced the average FRET ratio in MDA-MB-231, while cells treated with CN03 had a higher average FRET ratio compared to those treated with Rhosin (Fig. S4).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!